Teleflex, which manufactures breathing tubes, catheters, and vascular access products for hospital intensive care units, carries a market value of roughly $5.5bn based on its most recent closing price of $124.75. Its shares surged 13.4% in after-hours trading following news of the approach. The company has been undergoing a significant strategic overhaul, having sold three business units for $2.03bn in December, and has faced pressure from activist investor Irenic Capital Management, which criticised its board in March for its reluctance to engage with potential buyers. CVC, Amsterdam-listed and managing approximately $241bn in assets, brings global private markets scale to the consortium. GTCR, the Chicago-based buyout firm, adds deep sector expertise, with a well-established track record in healthcare services and medical technology. Together, the two firms represent a formidable partnership for a deal of this complexity. Subscribe to our Newsletter to increase your edge. Don't...
learn more
